why choose us

Clinical Trials Search

Showing 15,680 of 132,656 result(s)
A Study of CTX-712 in Relapsed;Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Status: Completed

Condition: Acute Myeloid Leukemia

Interventions: CTX-712 will be provided as a 20 mg tablet for oral administration.
Patients will take CTX-712 weekly, depending on their dose level assignment,

Date: 2023-01-24

Decision Making Support for Parents and Caregivers

Status: Completed

Condition: Neonatal Critical Illness

Interventions: The tool will be used by parent(s) to help guide them in discussion with their infant's clinicians.

Date: 2023-01-24

HEPA, PM2.5, and Cardiometabolic Health

Status: Completed

Condition: Air Pollution

Interventions: HEPA filters with the capacity to reduce PM2.5 levels

Date: 2023-01-24

Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function

Status: Completed

Condition: Healthy Volunteer

Interventions: Day 1: A single dose of BEM will be administered

Date: 2023-01-24

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Status: Completed

Condition: Spinal Disease

Interventions: scan

Date: 2023-01-24

Impact of E-cigarette Device Warnings

Status: Completed

Condition: Vaping Behaviors

Interventions: Labels with e-cigarette health warning that include text about health harms of vaping will be applied to participants' vaping devices and refills

Date: 2023-01-24

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

Status: Completed

Condition: Liver Cancer

Interventions: Single fraction SBRT 27 Gy

Date: 2023-01-24

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Status: Completed

Condition: Advanced Biliary Tract Carcinoma

Interventions: Undergo blood sample collection

Date: 2023-01-24

Deucravacitinib for the Treatment of Palmoplantar Pustulosis

Status: Completed

Condition: Palmoplantar Pustulosis

Interventions: See arm;group description

Date: 2023-01-24

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Status: Completed

Condition: Opioid Use Disorder

Interventions: Throughout the 7-day inpatient study (Figure 1; Table 1), participants will receive sublingual BXCL501 or placebo twice daily and lofexidine or placeb

Date: 2023-01-24